| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/13/2005 | CN1639186A Inhibitors of kallikrein |
| 07/13/2005 | CN1639162A Pyrido(2, 1-a)isoquinoline derivatives as DPP-IV inhibitors |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1639157A 2-acylaminothiazole derivative or salt thereof |
| 07/13/2005 | CN1639150A 异喹啉衍生物 Isoquinoline derivatives |
| 07/13/2005 | CN1639139A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639120A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 07/13/2005 | CN1639115A Semicarbazide derivatives and their use as antithrombotics |
| 07/13/2005 | CN1638823A N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638791A Stable pharmaceutical composition comprising erythropoietin |
| 07/13/2005 | CN1638790A Compositions and methods for modulating connexin hemichannels |
| 07/13/2005 | CN1638788A Stabilized albumin preparaions |
| 07/13/2005 | CN1638771A Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636590A Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 07/13/2005 | CN1636575A Application of CMC grafted polyacrylic acid in preparing hemostatic and hemostatic material |
| 07/13/2005 | CN1636573A Vitamin-medicine composition and its use |
| 07/13/2005 | CN1636557A Simple production process for zinc citrate, zinc lactate, ferrous citrate and ferrous lactate |
| 07/13/2005 | CN1210400C Methods for making proteins contaniing free cysteine residues |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/13/2005 | CN1210061C Method of stabilizing protein C or activated protein C and stabilized composition obtained therefrom |
| 07/13/2005 | CN1210036C Novel usage of Aspirin-DL-Lysine |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916847 Anticoagulants; thrombosis; cardiovascular disorders |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
| 07/12/2005 | US6916810 αν integrin receptor antagonists |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916805 Therapeutic agents for treating or preventing disease states in mammals characterized by abnormal thrombosis |
| 07/12/2005 | US6916629 Tissue factor pathway inhibitor-3 |
| 07/12/2005 | US6916470 Methods for use of mpl ligands with primitive human stem cells |
| 07/12/2005 | US6916303 Photoreduction method for hemoglobin-vesicle |
| 07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
| 07/07/2005 | WO2005061523A1 Glycosaminoglycan (gag) mimetics |
| 07/07/2005 | US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 07/07/2005 | US20050148626 Novel thromodulin expression promoters |
| 07/07/2005 | US20050148624 Enzyme inhibitors with isoquinolinone structures |
| 07/07/2005 | US20050148619 Sulfonamido ether substituted imidazoquinolines |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148503 Comprises erythropoietin as active ingredient; for treatment of anemia, trypanosomiasis, or malaria |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | CA2551181A1 Glycosaminoglycan (gag) mimetics |
| 07/07/2005 | CA2546943A1 Novel compounds |
| 07/06/2005 | EP1550455A1 Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation |
| 07/06/2005 | EP1550442A1 Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1634970A Process for preparing notoginsen triterpenes |
| 07/06/2005 | CN1634912A Acetyl salicyl puerarin derivatives and preparation method and use thereof |
| 07/06/2005 | CN1634613A Plant source alcohol soluble protein and its preparation method |
| 07/06/2005 | CN1634576A Medicine composition for improving stability of human urine kininogenase |
| 07/06/2005 | CN1634572A Biological collagen injection as substituted blood plasma and its preparation method |
| 07/06/2005 | CN1634550A Shumaikang pill |
| 07/06/2005 | CN1634535A Traditional Chinese medicine composition for treating iron-deficiency anemia |
| 07/06/2005 | CN1634525A Health-care food for regulating anemia |
| 07/06/2005 | CN1634524A Health-care food for improving nutritional anemia |
| 07/06/2005 | CN1634521A Medicine composition containing extracts of curcuma zedoaria and red ginseng, and preparation method and application thereof |
| 07/06/2005 | CN1634493A Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract |
| 07/06/2005 | CN1634457A Freeze dried of root rhizome and herb of common lamiophlomis and preparation method thereof |
| 07/06/2005 | CN1634444A Nudiflower beautyberry leaf capsule or granule and preparation method thereof |
| 07/06/2005 | CN1634433A Embolism eliminatinging drop pills with qi invigorating, blood flow promoting and collateral dredging function |
| 07/06/2005 | CN1634426A Composition of fresh rehmannia root and rhubarb horsetails and preparation method thereof |
| 07/06/2005 | CN1634419A Capsule with diuresis promoting function containing amber and toad |
| 07/06/2005 | CN1634403A Red sage root ligustrazine freeze dried injecta and preparation method thereof |
| 07/06/2005 | CN1634291A Chinese traditional medicine with thrombus eliminating and brain caring function and preparation method thereof |
| 07/06/2005 | CN1634254A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 07/06/2005 | CN1634250A Compound injectio of Chinese angelica and astragalus root and its preparing process |
| 07/06/2005 | CN1634245A Formulation for dredging thrombus and its preparing method |
| 07/06/2005 | CN1634243A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 07/06/2005 | CN1634241A Compound formulation of notoginseng for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 07/06/2005 | CN1634213A Chinese medicinal formulation for hematogenesis |
| 07/06/2005 | CN1634141A Ass hide gel formulation and its preparing process |
| 07/06/2005 | CN1634138A Universal blood product having biologicalactivity of natural whole blood |
| 07/06/2005 | CN1634114A Clindamycin phosphate orally disintegrating tablet |
| 07/06/2005 | CN1634085A Injectio of aspirin and dipyridamole and its preparing process |
| 07/06/2005 | CN1634080A Spironolactone dripping pills |